Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children
- PMID: 33181582
- DOI: 10.1097/MPH.0000000000002003
Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children
Abstract
Mucositis, a painful and debilitating condition, is a common side effect of chemotherapy. The role of tramadol in the treatment of mucositis in pediatric patients has not yet been determined. In this retrospective study, we evaluate whether tramadol as single agent achieved a reduction of pain intensity among oncologic children admitted for mucositis. In total, 34 of 54 (63%) episodes were treated with tramadol alone and achieved adequate pain relief. Tramadol's side effects were mild and manageable.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Hurrell L, Burgoyne L, Logan R, et al. The management of pediatric oncology inpatients with oral mucositis. J Pediatr Hematol Oncol. 2019;41:e510–e516.
-
- WHO. WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children With Medical Illnesses; 2012. Available at: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&am... . Accessed January 1, 2012.
-
- Wiffen PJ, Cooper TE, Anderson AK, et al. Opioids for cancer-related pain in children and adolescents. Cochrane Database Syst Rev. 2017;7:CD012564.
-
- Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879–923.
-
- Zernikow B, Smale H, Michel E, et al. Paediatric cancer pain management using the WHO analgesic ladder—results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain. 2006;10:587–595.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources